Today@Dal

Researchers would like to develop a vaccine against CMV. The goal of a CMV vaccine would be to prevent CMV infection so that women would not pass the infection to their fetus. CMV infection of the developing fetus/baby be harmful, including causing hearing loss (deafness) and harming the brain's ability to develop. To date, there is no licensed vaccine against CMV.

Participants needed: Men and women between 18-40 years of age.

If you are interested in participating in this study, please contact Jill:

jill.mutch@iwk.nshealth.ca
470-3860

http://centerforvaccinology.ca/study/cmv-study/